Rigel Pharmaceuticals Inc
F:RI2A
Rigel Pharmaceuticals Inc
F:RI2A
Price:
10.8
EUR
1.89%
Market Closed
Market Cap:
€21.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Rigel Pharmaceuticals Inc
F:RI2A
|
US |
|
Danaos Corp
F:DVW1
|
GR |
|
I
|
Interface Inc
F:IF6N
|
US |
Shareholder Yield
Current shareholder yield for 
RI2A is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
RI2A Price
Rigel Pharmaceuticals Inc
Rigel Pharmaceuticals Inc
Annual Price Range
10.8
52w Low
N/A
52w High
N/A
Price Metrics
| Average Annual Return | -32.22% |
| Standard Deviation of Annual Returns | 9.39% |
| Max Drawdown | -83% |
Shares Statistics
| Market Capitalization | 593.8m EUR |
| Shares Outstanding | 2 029 550 |
| Percentage of Shares Shorted |
N/A
|
RI2A Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
RI2A's latest stock split occurred on Jun 27, 2024
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, RI2A traded at 0.772 per share. Afterward, the share price was about 7.72.
The adjusted shares began trading on Jun 27, 2024. This was the only stock split in RI2A's history.
Pre-Split Price
7.72
0.772
Post-Split Price
7.72
Before
After
